Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01960088 · ClinicalTrials.gov registry record
Adolescent Vaccination in Pharmacies
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 1,509
- Enrollment target
NCT01960088: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT01960088 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01960088 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 1,509 participants
- Enrollment target
Study Summary
The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.
Primary Outcome
Outcome is for the national survey of parents.
Interventions
- DRUG HPV vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,509 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-04 |
What the finished NCT01960088 record still lists
NCT01960088 is an observational study that tracks outcomes without assigning an intervention. Its 1,509 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which HPV vaccine is the first listed.
NCT01960088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01960088 about?
NCT01960088 is a clinical study titled "Adolescent Vaccination in Pharmacies". The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the sec...
What is the current status of trial NCT01960088?
This trial is currently completed. The enrollment target is 1,509 participants. The study started on 2015-07. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01960088?
The interventions under investigation include: HPV vaccine (DRUG).
Who is sponsoring clinical trial NCT01960088?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia